Follow @keithspeights
Recent articles
Why Mallinckrodt Stock Is Tanking Today
The company filed a lawsuit to stop a federal decision that could be very bad news for its top drug.
Aurora Cannabis, Cronos Group, and Tilray Earnings Results Are In: Here's What They Could Mean for Canopy Growth
Based on its peers' results, Canopy Growth could be in for a pretty good quarter.
Aurora Cannabis Had a Great Quarter -- but Here's What We Still Don't Know
Unanswered questions for the marijuana producer could keep the stock from flying as high as it could.
Better Buy: Vertex Pharmaceuticals vs. Galapagos
Two rising biotech stocks. One clear long-term winner.
3 Healthcare Stocks I'd Buy Right Now
They're leaders in their markets. And those markets should grow tremendously.
3 Biotech Stocks That Soared Last Week: Are They Buys?
Can these high-flying biotech stocks keep the momentum going?
Better Buy: Intercept Pharmaceuticals vs. Gilead Sciences
These two biotechs could have a tortoise-and-hare kind of race going on.
Better Buy: Eli Lilly vs. Pfizer
Which stock wins in a matchup between these two big drugmakers?
Top 5 New Drug Launches of 2019 -- and the Biotech Stocks That Could Win Big
These drugs and the biotechs that make them could be on the way to tremendous success in the near future.
Better Buy: Novavax vs. Inovio Pharmaceuticals
Which stock wins in a head-to-head matchup between these two clinical-stage biotechs?
Better Buy: Aphria vs. Aurora Cannabis
One of these marijuana stocks has been the bigger winner recently. But which is better poised to win in the future?
3 Small-Cap Biotech Stocks You Can Buy Right Now
They're risky. You'll have to wait years before any significant revenue comes in. But these biotech stocks could be huge winners.
4 Reasons Tilray Stock Could Soar This Year
But there are also two reasons that it might not.
Why ImmunoGen Shares Are Crashing Today
Disappointing news from the FDA means that the biotech company is further from potentially winning approval for its lead drug candidate.
5 Tremendously Important Numbers in Aurora Cannabis' Q3 Results You Might Have Overlooked
Sure, Aurora's Q3 revenue growth was fantastic. But here's what the company reported that points to an even brighter future.
Aurora Cannabis Keeps Its Momentum Going in Q3
The Canadian cannabis producer delivered skyrocketing revenue growth but a widening net loss in the third quarter.
What's on the Way From Canopy Growth Based on Its Latest U.S. Trademark Applications
The Canadian cannabis producer appears to be set to make its mark in the potentially lucrative U.S. hemp market.
3 Top Healthcare Stocks to Buy in May
These look like great picks to buy in May before you go away.
3 Things That Fueled Tilray's Tremendous Revenue Jump in Q1
The Canadian marijuana producer's revenue nearly tripled year over year in Q1. Here's why.
Why TransEnterix Stock Jumped Today
An analyst upgrade fueled optimism for the beaten-down stock.